Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases

by Marta Pajares, Antonio Cuadrado, Ana I. Rojo
Published 2017-04-01

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

by Marta Pajares, Ana I. Rojo, Gina Manda, Lisardo Boscá, Antonio Cuadrado
Published 2020-07-01

Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach

by Norwin Kubick, Marta Pajares, Ioana Enache, Gina Manda, Michel-Edwar Mickael
Published 2020-05-01

Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy

by Ana I. Rojo, Marta Pajares, Angel J. García-Yagüe, Izaskun Buendia, Fred Van Leuven, Masayuki Yamamoto, Manuela G. López, Antonio Cuadrado
Published 2018-09-01

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology

by Ana I. Rojo, Marta Pajares, Patricia Rada, Angel Nuñez, Alejo J. Nevado-Holgado, Richard Killik, Fred Van Leuven, Elena Ribe, Simon Lovestone, Masayuki Yamamoto, Antonio Cuadrado
Published 2017-10-01

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas

by Maribel Escoll, Diego Lastra, Marta Pajares, Natalia Robledinos-Antón, Ana I. Rojo, Raquel Fernández-Ginés, Marta Mendiola, Virginia Martínez-Marín, Isabel Esteban, Pilar López-Larrubia, Ricardo Gargini, Antonio Cuadrado
Published 2020-02-01